Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > ADMEcell Enters into Agreement with Advancell

Abstract:
ADMEcell, announced that it has entered into an exclusive agreement with Advancell, Barcelona, Spain, to manufacture and distribute the CacoReady™ System for the North American market. The CacoReady™ System is a new, innovative tool designed to optimize the time and costs of evaluating the intestinal absorption of compounds. The kit has been designed to provide a Ready-To-Use user-friendly kit and suitable for high-throughput automated procedures. It provides users with the differentiated Caco-2 barrier (21-day system), plated on 24- or 96-Transwell plates.

ADMEcell Enters into Agreement with Advancell

EMERYVILLE, CA | Posted on March 13th, 2009

"This kit with differentiated Caco-2 cell barriers is an innovation that is being offered in North America for the first time," says Sandy Koshkin, President of ADMEcell. "Our customers gain considerable savings of both cost and time." The CacoReady product is shipped in proprietary shipping media at room temperature, and arrives ready for immediate use.

####

About ADMEcell
ADMEcell, Inc. is an on-demand supplier of cell-based assay kits servicing the biotech and life sciences industries. Located in Emeryville, California, the company manufactures and distributes innovative and leading edge products through licensing and distribution agreements. ADMEcell’s product offerings enable rapid, sophisticated cell-based assays designed for in vitro therapeutic modeling and re-profiling. The common theme among the selected technologies is their leading edge nature and prominence within a chosen market.

ADMEcell is currently considering the licensing and/or distribution of unique cell-based assays that have important applications in the drug discovery process. Please contact ADMEcell in confidence if you have a unique, compelling cell-based assay that is relevant to the biotechnology and life science marketplace, particularly to ADME-toxicology.

About Advancell

Advancell, Barcelona, Spain, is a leader in nanomedicine and services and reagents in both ADME/Tox and Skin Biology areas, including cell-based assays. Advancell’s business model allows it to achieve reductions in costs, risks and the development time of a drug. Their most successful product to date is the CacoReady™ System. ADVANCELL operates throughout three divisions: Advancell Therapeutics, which is focused on development of new pharmaceutical application of known molecules through innovative testing; Advancell Alternative Testing, which uses in-vitro methods to predict cell efficiency, security, and the mechanism of molecule development, and Advancell Nanosystems, which uses nano-medicine to treat and prevent illnesses. Advancell has three different research centers in Spain. www.advancell.net

For more information, please click here

Contacts:
ADMEcell, Inc.
Sandy Koshkin, 877-236-3235

Copyright © Business Wire 2009

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Iranian Scientists Produce Transparent Nanocomposite Coatings with Longer Lifetime July 24th, 2014

Hysitron is Awarded TWO R&D 100 Awards for Highly Innovative Technology Developments in the Areas of Extreme Environments and Biological Mechanical Property Testing July 23rd, 2014

NNCO Announces an Interactive Webinar: Progress Review on the Coordinated Implementation of the National Nanotechnology Initiative 2011 Environmental, Health, and Safety Research Strategy July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Nanomedicine

Researchers create vaccine for dust-mite allergies Main Page Content: Vaccine reduced lung inflammation to allergens in lab and animal tests July 22nd, 2014

NIST shows ultrasonically propelled nanorods spin dizzyingly fast July 22nd, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

More than glitter: Scientists explain how gold nanoparticles easily penetrate cells, making them useful for delivering drugs July 21st, 2014

Announcements

Iranian Scientists Produce Transparent Nanocomposite Coatings with Longer Lifetime July 24th, 2014

UCF Nanotech Spinout Developing Revolutionary Battery Technology: Power the Next Generation of Electronics with Carbon July 23rd, 2014

Deadline Announced for Registration in 7th Int'l Nanotechnology Festival in Iran July 23rd, 2014

A Crystal Wedding in the Nanocosmos July 23rd, 2014

Tools

Hysitron is Awarded TWO R&D 100 Awards for Highly Innovative Technology Developments in the Areas of Extreme Environments and Biological Mechanical Property Testing July 23rd, 2014

EPFL Research on the use of AFM based nanoscale IR spectroscopy for the study of single amyloid molecules wins poster competition at Swiss Physics Society meeting July 22nd, 2014

The Hiden EQP Plasma Diagnostic with on-board MCA July 22nd, 2014

Nanometrics Announces Upcoming Investor Events July 22nd, 2014

Alliances/Partnerships/Distributorships

Organometallics welcomes new editor-in-chief: Paul Chirik, Ph.D. July 22nd, 2014

Haydale and Goodfellow Announce Major Distribution Agreement for Functionalised Graphene Materials July 21st, 2014

SentiMag® Now Available in Australia and New Zealand July 21st, 2014

Martini Tech Inc. becomes the exclusive distributor for Yoshioka Seiko Co. porous chucks for Europe and North America July 20th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE